相关实验视频

Updated: May 14, 2025

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

多模式质瘤免疫疗法结合了针对TLR9的STAT3反感性寡氧核酸与PD1免疫检查点阻塞

Chia-Yang Hung¹, Elaine Y Kang¹, Karol Jacek²

¹Department of Immuno-Oncology; City of Hope Beckman Research Institute and Medical Center; Duarte, CA, USA.

|April 11, 2025

概括

一种新型的STAT3反感性寡核酸 (CpG-STAT3dsASO) 向质瘤细胞和骨髓状细胞,增强免疫疗法. 与抗PD1的联合治疗促进T细胞反应和质母细胞瘤的回归.

科学领域:

神经瘤学神经瘤学
免疫治疗是一种免疫疗法.
氧核酸治疗药物治疗药物

背景情况:

质母细胞瘤 (GBM) 由于异质性,免疫特权和宽容的微环境而表现出治疗耐药性.
信号传感器和转录3激活器 (STAT3) 对质瘤细胞存活和免疫逃避至关重要,有助于GBM耐药性.

研究的目的:

开发和评估一种新型的细胞选择性双链STAT3抗意义寡核化物 (CpG-STAT3dsASO),用于向质瘤细胞和质瘤相关髓状细胞 (GAMs).
评估CpG-STAT3dsASO在 ортотоп GBM 模型中的安全性和有效性.

主要方法:

开发一种细胞选择性的双链STAT3抗意义寡核酸 (CpG-STAT3dsASO).
在免疫能力和免疫缺陷的小鼠中对寡核酸的安全性和有效性的评估与正确的GBM.
评估CpG-STAT3dsASO单疗法和与PD1抑制的联合疗法.

主要成果:

CpG-STAT3dsASO耐受性良好,减少了GBM的进展,并且在免疫能力强的小鼠中没有诱导神经毒性.
CpG-STAT3dsASO激活了内GAMs,增加了CD4+Th1细胞,并减少了TREGs.
组合疗法 (CpG-STAT3dsASO/anti-PD1) 通过增强CD8+T细胞活性和内免疫细胞相互作用,诱导显著的质瘤回归和长期存活率.

结论:

CpG-STAT3dsASO在GBM中破坏了GAM介导的免疫逃避.
这种方法恢复了对PD1阻断的敏感性,促进了T细胞介导的抗瘤反应.
CpG-STAT3dsASO代表了增强GBM免疫疗法的有希望的策略.

关键词:

质母细胞瘤 (glioblastoma) 是一个这就是PD1 PD1.在STAT3中,我们可以使用STAT3.在TLR9中,这是一种反意义的寡核酸.

更多相关视频

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on: October 27, 2014

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells

Published on: November 28, 2015

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.